PBH treatment
搜索文档
Amylyx Pharmaceuticals (NasdaqGS:AMLX) 2026 Conference Transcript
2026-05-14 05:42
Amylyx Pharmaceuticals (NasdaqGS:AMLX) 2026 Conference May 13, 2026 04:40 PM ET Speaker0 Company presenter at the Bank of America Annual Healthcare Conference. My name is Jason Gerber. I cover pharm and biotech. I'm pleased to be introducing Amylyx Pharmaceuticals and Joshua Cohen, Co-Chief Executive Officer. This is an interesting time for Amylyx on the cusp of pivotal Phase III data expected in the 3rd quarter, a transformational event. I imagine a lot of our discussion is gonna be focused on the lead pro ...